YU197387A - Process for producing izophamide-liophilizate - Google Patents

Process for producing izophamide-liophilizate

Info

Publication number
YU197387A
YU197387A YU01973/87A YU197387A YU197387A YU 197387 A YU197387 A YU 197387A YU 01973/87 A YU01973/87 A YU 01973/87A YU 197387 A YU197387 A YU 197387A YU 197387 A YU197387 A YU 197387A
Authority
YU
Yugoslavia
Prior art keywords
liophilizate
izophamide
producing
ifosfamide
weight
Prior art date
Application number
YU01973/87A
Other languages
English (en)
Inventor
D Sauerbier
U P Dammann
O Isaac
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of YU197387A publication Critical patent/YU197387A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Control Of El Displays (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Indole Compounds (AREA)
  • Amplifiers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
YU01973/87A 1986-10-31 1987-10-30 Process for producing izophamide-liophilizate YU197387A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3637089 1986-10-31

Publications (1)

Publication Number Publication Date
YU197387A true YU197387A (en) 1988-12-31

Family

ID=6312873

Family Applications (1)

Application Number Title Priority Date Filing Date
YU01973/87A YU197387A (en) 1986-10-31 1987-10-30 Process for producing izophamide-liophilizate

Country Status (25)

Country Link
EP (1) EP0265812B1 (ko)
JP (1) JPS63159319A (ko)
KR (1) KR900003491B1 (ko)
AT (1) ATE55250T1 (ko)
AU (1) AU598602B2 (ko)
CA (1) CA1314231C (ko)
DD (1) DD262582A5 (ko)
DE (1) DE3764235D1 (ko)
DK (1) DK169308B1 (ko)
EG (1) EG18333A (ko)
ES (1) ES2017982B3 (ko)
FI (1) FI87140C (ko)
GE (1) GEP19971025B (ko)
GR (1) GR3000708T3 (ko)
HU (1) HU197987B (ko)
IL (1) IL84312A (ko)
IN (1) IN168119B (ko)
LV (1) LV10051B (ko)
MX (1) MX8958A (ko)
NO (1) NO873860L (ko)
PT (1) PT86032B (ko)
RU (1) RU1836079C (ko)
UA (1) UA11075A (ko)
YU (1) YU197387A (ko)
ZA (1) ZA878183B (ko)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE58900183D1 (de) * 1988-03-19 1991-08-29 Asta Pharma Ag Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.
US5227373A (en) * 1991-10-23 1993-07-13 Bristol-Myers Squibb Co. Lyophilized ifosfamide compositions
WO1995007083A1 (en) * 1993-09-10 1995-03-16 F.H. Faulding & Co. Limited Ifosfamide lyophilisate composition
DE19529057B4 (de) * 1995-08-08 2007-12-13 Baxter Healthcare S.A. Ifosfamid-Lyophilisat-Zubereitungen
NZ506578A (en) * 1998-03-03 2003-09-26 Shionogi & Co Pharmaceutical compositions containing the phospholipase inhibitor sodium [[3-(2-amino-1,2-dioxoethyl)- 2-ethyl-1-phenylmethyl)-1h-indol-4-yl]oxy]acetate
CA2497898C (en) * 2002-09-05 2012-02-07 Bharat Serums & Vaccines Ltd. Liquid stable composition of oxazaphosphorine with mesna
BR0316968A (pt) * 2002-12-02 2005-10-25 Bharat Serums & Vaccines Ltd Composições estáveis, claras, aquosas de ifosfamida para administração parenteral que apresentam pouca toxicidade; processo para a preparação de composições de ifosfamida; e composições de ifosfamida e um processo para a preparação das mesmas
US8436190B2 (en) * 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
MX2009003197A (es) * 2006-09-29 2009-05-08 Infa Sa Sistema de embalaje para composiciones farmaceuticas y equipo para administracion intravenosa.
WO2016087001A1 (en) * 2014-12-04 2016-06-09 Huawei Technologies Co., Ltd. Load allocation in a data communication network

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3732340A (en) * 1966-07-11 1973-05-08 Asta Werke Ag Chem Fab N',o-propylene phosphoric acid ester diamides
DE2750207A1 (de) * 1977-05-09 1978-11-16 Walton J Smith Gefriergetrocknete zusammensetzungen, insbesondere gefriergetrocknete pharmazeutische praeparate und verfahren zu deren herstellung
DE3279834D1 (en) * 1981-12-31 1989-08-31 Asta Pharma Ag 4-sulfido-oxaza phosphorines and their use in the treatment of cancer, and in immunosuppression
US4537883A (en) * 1982-11-12 1985-08-27 Mead Johnson & Company Lyophilized cyclophosphamide

Also Published As

Publication number Publication date
FI874727A0 (fi) 1987-10-27
ES2017982B3 (es) 1991-03-16
AU8052987A (en) 1988-05-05
EG18333A (en) 1993-12-30
GR3000708T3 (en) 1991-10-10
NO873860L (no) 1988-05-02
EP0265812B1 (de) 1990-08-08
MX8958A (es) 1993-12-01
LV10051B (en) 1995-06-20
IN168119B (ko) 1991-02-09
UA11075A (uk) 1996-12-25
KR900003491B1 (ko) 1990-05-21
DE3764235D1 (de) 1990-09-13
KR880004814A (ko) 1988-06-27
LV10051A (lv) 1994-05-10
PT86032B (pt) 1990-08-31
FI874727A (fi) 1988-05-01
DK569687A (da) 1988-05-01
HU197987B (en) 1989-07-28
AU598602B2 (en) 1990-06-28
IL84312A (en) 1991-11-21
DK169308B1 (da) 1994-10-10
RU1836079C (ru) 1993-08-23
DK569687D0 (da) 1987-10-30
DD262582A5 (de) 1988-12-07
NO873860D0 (no) 1987-09-15
IL84312A0 (en) 1988-03-31
JPH0543684B2 (ko) 1993-07-02
GEP19971025B (en) 1997-04-06
ZA878183B (en) 1988-05-02
HUT44932A (en) 1988-05-30
FI87140C (fi) 1992-12-10
ATE55250T1 (de) 1990-08-15
FI87140B (fi) 1992-08-31
CA1314231C (en) 1993-03-09
EP0265812A1 (de) 1988-05-04
PT86032A (de) 1987-11-01
JPS63159319A (ja) 1988-07-02

Similar Documents

Publication Publication Date Title
EP0498471A3 (en) Liposomes comprising a guanidino aminoglycoside
HU905862D0 (en) Process for producing epy-podophyllotoxin-glycoside-4'phosphate derivatives
GR3002377T3 (en) Ifosfamide-mesna-lyophilized composition and process to prepare it
HUT48266A (en) Process for producing 2,3'-dideoxy-2'-fluoronukleozides and pharmaceutical compositions containing them as active componenets
YU197387A (en) Process for producing izophamide-liophilizate
IL101051A0 (en) Preparation of substituted tetrahydropyridines
PT84552A (en) Process for the preparation of a insecticidal composition containing bacterial spores and process for producing the reported spores
GR3001481T3 (en) Preparation of trichlorophenol
GR3003638T3 (ko)
EP0173753A4 (en) 6-SUBSTITUTED PROSTAGLANDINE E 1 AND THEIR PRODUCTION.
ZA865148B (en) Preparation of 4,5-dihydrodithieno(3,4-b:3',4'-e)azepine-5,9-dione
HUT46693A (en) Process for producing dioxabicyclo/3,3,0/oktanon-oxim-ethers and pharmaceutical compositions containing them as active components
EP0415564A3 (en) Improvement of excretion of nonprotein nitrogen into the intestine by prostanoic acid derivaties
AU7790787A (en) Process for the preparation of N,N'-tetrathiodimorpholine
ZA883610B (en) A process for the preparation of 5-acylamino-2,4,6-triiodo-or tribromo-benzioc acid derivatives and the acid derivatives obtained by said process
GR890300022T1 (en) Process for the preparation of 5-hydroxydipraphenone and its salts with acids
PL250235A2 (en) Process for preparing 2,5-dinitrate of 1,4:3,6-dianhydro-d-sorbite
YU116389A (en) Process for preparing derivatives of 1,3-diazolyl-2-propanole
PT81639A (en) Process of preparation of a by product of 2,3-dihydre-2-oxoindole
CS490187A1 (en) Method of 2,5-dibutoxy-4-morpholine-benzendiazononium preparation
CS967587A1 (en) Method of 2,6-dialkyl-n-/l-methoxy-2-propyl-aniline preparation
AU7250987A (en) Pharmaceutical compositions for use in improving oxygenation of the brain and a process for their production